136 related articles for article (PubMed ID: 4630161)
1. The use of physical and animal models to assess bioavailability.
Barr WH
Pharmacology; 1972; 8(1):55-101. PubMed ID: 4630161
[No Abstract] [Full Text] [Related]
2. Physiological and pharmacokinetic complexities in bioavailability testing.
Riegelman S
Pharmacology; 1972; 8(1):118-41. PubMed ID: 4644643
[No Abstract] [Full Text] [Related]
3. Proceedings: Mechanisms of drug absorption and of drug solution.
Jollow DJ
Rev Can Biol; 1973; 32():Suppl:7-19. PubMed ID: 4777606
[No Abstract] [Full Text] [Related]
4. Mechanisms of drug absorption and of drug solution.
Jollow DJ; Brodie BB
Pharmacology; 1972; 8(1):21-32. PubMed ID: 4644653
[No Abstract] [Full Text] [Related]
5. [Influence of the starting materials on bioavailability of drugs].
Bagnaresi P; Bulgarelli D; Calvi A; Ferrarini G
Boll Chim Farm; 1973 Feb; 112(2):83-93. PubMed ID: 4719968
[No Abstract] [Full Text] [Related]
6. Proceedings: Bioavailability and therapeutic efficacy.
Withey RJ
Rev Can Biol; 1973; 32():Suppl:21-30. PubMed ID: 4777602
[No Abstract] [Full Text] [Related]
7. Dose-dependent drug metabolism during the absorptive phase.
Barr WH; Aceto T; Chung M; Shukur M
Rev Can Biol; 1973; 32():Suppl:33-42. PubMed ID: 4791683
[No Abstract] [Full Text] [Related]
8. Salicylate metabolism in man.
Davison C
Ann N Y Acad Sci; 1971 Jul; 179():249-68. PubMed ID: 4998910
[No Abstract] [Full Text] [Related]
9. [Significance and problems of biopharmacy].
Mielck JB; Speiser PP
Pharmazie; 1971 Nov; 26(11):652-5. PubMed ID: 5154313
[No Abstract] [Full Text] [Related]
10. Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination.
Schumacher GE
Am J Hosp Pharm; 1972 Apr; 29(4):339-43. PubMed ID: 5025265
[No Abstract] [Full Text] [Related]
11. Bioavailability of drugs (first of two parts).
Koch-Weser J
N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408
[No Abstract] [Full Text] [Related]
12. Proceedings: Effect of mucin on the bioavailability of tetracycline from the gastro-intestinal tract: in vivo, in vitro correlations.
Barry BW; Braybrooks MP
J Pharm Pharmacol; 1974 Dec; 26 Suppl():64P-65P. PubMed ID: 4156744
[No Abstract] [Full Text] [Related]
13. In vitro drug release rate as a standard requirement.
Láng B
Pharmazie; 1971 Nov; 26(11):661-4. PubMed ID: 5154319
[No Abstract] [Full Text] [Related]
14. Keeping bioavailability in perspective.
Schumacher GE
Am J Hosp Pharm; 1973 Feb; 30(2):150-4. PubMed ID: 4690469
[No Abstract] [Full Text] [Related]
15. Apparent directional permeability coefficients for drug ions: in vitro intestinal perfusion studies.
Turner RH; Mehta CS; Benet LZ
J Pharm Sci; 1970 May; 59(5):590-5. PubMed ID: 5446410
[No Abstract] [Full Text] [Related]
16. Examples of developing in vitro-in vivo relationships.
Butler J
Adv Exp Med Biol; 1997; 423():93-110. PubMed ID: 9269486
[No Abstract] [Full Text] [Related]
17. Intestinal absorption of aspirin. Influence of pH, taurocholate, ascorbate, and ethanol.
Hollander D; Dadufalza VD; Fairchild PA
J Lab Clin Med; 1981 Oct; 98(4):591-8. PubMed ID: 7288271
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacology and practical therapy. Principles for the selection of application form of a drug and its mode of origin].
Levy G; Barr WH
Internist (Berl); 1973 Dec; 14(12):661-7. PubMed ID: 4593013
[No Abstract] [Full Text] [Related]
19. [Differentiation of the degree of bioavailability of peroral drug forms of tetracycline hydrochloride in experiments on laboratory animals].
Zak AF; Ermolova OB
Antibiotiki; 1976 Feb; 21(2):151-5. PubMed ID: 1275466
[TBL] [Abstract][Full Text] [Related]
20. Particle size of drugs and its relationship to absorption and activity.
Fincher JH
J Pharm Sci; 1968 Nov; 57(11):1825-35. PubMed ID: 4881918
[No Abstract] [Full Text] [Related]
[Next] [New Search]
